Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 1999; Volume 55,Issue 6

MINIREVIEW

  • You have access
    Rho as a Mediator of G Protein-Coupled Receptor Signaling
    Tammy M. Seasholtz, Mousumi Majumdar and Joan Heller Brown
    Molecular Pharmacology June 1999, 55 (6) 949-956; DOI: https://doi.org/10.1124/mol.55.6.949

Articles

  • You have access
    A Regulatory Domain (R1–R2) in the Amino Terminus of theN-Methyl-d-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein
    Takashi Masuko, Keiko Kashiwagi, Tomoko Kuno, Nguyen D. Nguyen, Albert J. Pahk, Jun-ichi Fukuchi, Kazuei Igarashi and Keith Williams
    Molecular Pharmacology June 1999, 55 (6) 957-969; DOI: https://doi.org/10.1124/mol.55.6.957
  • You have access
    Activation and Ca2+ Permeation of Stably Transfected α3/β4 Neuronal Nicotinic Acetylcholine Receptor
    J. Zhang, Y. Xiao, G. Abdrakhmanova, W. Wang, L. Cleemann, K.J. Kellar and M. Morad
    Molecular Pharmacology June 1999, 55 (6) 970-981; DOI: https://doi.org/10.1124/mol.55.6.970
  • You have access
    Effect of Mutations within the Peripheral Anionic Site on the Stability of Acetylcholinesterase
    Nathalie Morel, Suzanne Bon, Harry M. Greenblatt, Daniel Van Belle, Shoshana J. Wodak, Joel L. Sussman, Jean Massoulié and Israel Silman
    Molecular Pharmacology June 1999, 55 (6) 982-992; DOI: https://doi.org/10.1124/mol.55.6.982
  • You have access
    Residues in Transmembrane Domains I and II Determine γ-Aminobutyric Acid Type AA Receptor Subtype-Selective Antagonism by Furosemide
    S.A. Thompson, S.A. Arden, G. Marshall, P.B. Wingrove, P.J. Whiting and K.A. Wafford
    Molecular Pharmacology June 1999, 55 (6) 993-999; DOI: https://doi.org/10.1124/mol.55.6.993
  • You have access
    Pharmacological and Histochemical Distinctions Between Molecularly Defined Sarcolemmal KATP Channels and Native Cardiac Mitochondrial KATP Channels
    Hai Hu, Toshiaki Sato, Jegatheesan Seharaseyon, Yongge Liu, David C. Johns, Brian O’Rourke and Eduardo Marbán
    Molecular Pharmacology June 1999, 55 (6) 1000-1005; DOI: https://doi.org/10.1124/mol.55.6.1000
  • You have access
    Detection of Nitrosyl Hemoglobin in Venous Blood in the Treatment of Sickle Cell Anemia with Hydroxyurea
    Richard E. Glover, Edward D. Ivy, Eugene P. Orringer, Hiroshi Maeda and Ronald P. Mason
    Molecular Pharmacology June 1999, 55 (6) 1006-1010; DOI: https://doi.org/10.1124/mol.55.6.1006
  • You have access
    Agonist and Potentiation Actions of n-Octanol on γ-Aminobutyric Acid Type A Receptors
    Yasutaka Kurata, William Marszalec, Jay Z. Yeh and Toshio Narahashi
    Molecular Pharmacology June 1999, 55 (6) 1011-1019; DOI: https://doi.org/10.1124/mol.55.6.1011
  • You have access
    Bombesin Receptors Inhibit G Protein-Coupled Inwardly Rectifying K+ Channels Expressed in Xenopus Oocytes through a Protein Kinase C-Dependent Pathway
    Edward B. Stevens, Bhaval S. Shah, Robert D. Pinnock and Kevin Lee
    Molecular Pharmacology June 1999, 55 (6) 1020-1027; DOI: https://doi.org/10.1124/mol.55.6.1020
  • You have access
    Relationship between Internalization and mRNA Decay in Down-Regulation of Recombinant Type 1 Angiotensin II Receptor (AT1) Expression in Smooth Muscle Cells
    Brian Adams, Tracy S. Obertone, Xiaofei Wang and T. J. Murphy
    Molecular Pharmacology June 1999, 55 (6) 1028-1036; DOI: https://doi.org/10.1124/mol.55.6.1028
  • You have access
    Molecular Determinants of (+)-Tubocurarine Binding at Recombinant 5-Hydroxytryptamine3A Receptor Subunits
    Anthony G. Hope, Delia Belelli, Ian D. Mair, Jeremy J. Lambert and John A. Peters
    Molecular Pharmacology June 1999, 55 (6) 1037-1043; DOI: https://doi.org/10.1124/mol.55.6.1037
  • You have access
    Nontransportable Inhibitors Attenuate Reversal of Glutamate Uptake in Synaptosomes Following a Metabolic Insult
    H. P. Koch, A. R. Chamberlin and R. J. Bridges
    Molecular Pharmacology June 1999, 55 (6) 1044-1048; DOI: https://doi.org/10.1124/mol.55.6.1044
  • You have access
    Mechanism of Inhibition of a Poxvirus Topoisomerase by the Marine Natural Product Sansalvamide A
    Young Hwang, David Rowley, Denise Rhodes, Jeff Gertsch, William Fenical and Frederic Bushman
    Molecular Pharmacology June 1999, 55 (6) 1049-1053; DOI: https://doi.org/10.1124/mol.55.6.1049
  • You have access
    The Amino Terminus of Receptor Activity Modifying Proteins Is a Critical Determinant of Glycosylation State and Ligand Binding of Calcitonin Receptor-Like Receptor
    Neil J. Fraser, Alan Wise, Jason Brown, Linda M. McLatchie, Martin J. Main and Steven M. Foord
    Molecular Pharmacology June 1999, 55 (6) 1054-1059; DOI: https://doi.org/10.1124/mol.55.6.1054
  • You have access
    Stoichiometry of Sulfonylurea-Induced ATP-Sensitive Potassium Channel Closure
    Henrik Dörschner, Edelweiss; Brekardin, Ingo Uhde, Christina Schwanstecher and Mathias Schwanstecher
    Molecular Pharmacology June 1999, 55 (6) 1060-1066; DOI: https://doi.org/10.1124/mol.55.6.1060
  • You have access
    Differential Regulation of Peptide α-Amidation by Dexamethasone and Disulfiram
    William J. Driscoll, S. Alyssa Mueller, Betty A. Eipper and Gregory P. Mueller
    Molecular Pharmacology June 1999, 55 (6) 1067-1076; DOI: https://doi.org/10.1124/mol.55.6.1067
  • You have access
    Selective Recognition of Vitamin D Receptor Conformations Mediates Promoter Selectivity of Vitamin D Analogs
    Marcus Quack and Carsten Carlberg
    Molecular Pharmacology June 1999, 55 (6) 1077-1087; DOI: https://doi.org/10.1124/mol.55.6.1077
  • You have access
    Overexpression of p21waf1 Decreases G2-M Arrest and Apoptosis Induced by Paclitaxel in Human Sarcoma Cells Lacking Both p53 and Functional Rb Protein
    WeiWei Li, Jianguo Fan, Debabrata Banerjee and Joseph R. Bertino
    Molecular Pharmacology June 1999, 55 (6) 1088-1093; DOI: https://doi.org/10.1124/mol.55.6.1088
  • You have access
    Inhibition of Cyclic AMP Response Element-Binding Protein/Cyclic AMP Response Element-Mediated Transcription by the Immunosuppressive Drugs Cyclosporin A and FK506 Depends on the Promoter Context
    Gero Siemann, Roland Blume, Daniela Grapentin, Elke Oetjen, Markus Schwaninger and Willhart Knepel
    Molecular Pharmacology June 1999, 55 (6) 1094-1100; DOI: https://doi.org/10.1124/mol.55.6.1094

Accelerated Communication

  • You have access
    Cloning and Functional Expression of the Human Histamine H3 Receptor
    Timothy W. Lovenberg, Barbara L. Roland, Sandy J. Wilson, Xiaoxia Jiang, Jayashree Pyati, Arne Huvar, Michael R. Jackson and Mark G. Erlander
    Molecular Pharmacology June 1999, 55 (6) 1101-1107; DOI: https://doi.org/10.1124/mol.55.6.1101

Errata

  • You have access
    Molecular Pharmacology June 1999, 55 (6) 1108; DOI: https://doi.org/10.1124/mol.55.6.1108-a
  • You have access
    Molecular Pharmacology June 1999, 55 (6) 1108; DOI: https://doi.org/10.1124/mol.55.6.1108
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 55 (6)
Molecular Pharmacology
Vol. 55, Issue 6
1 Jun 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • MINIREVIEW
  • Articles
  • Accelerated Communication
  • Errata
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics